The Research and Development team at Corner Therapeutics is dedicated to pioneering innovative immunotherapies using their unique dendritic cell hyperactivation (hDC) platform. They conduct advanced research to enhance memory T cell responses, aiming to create robust, durable, and cost-effective treatments for a wide range of cancers and infectious diseases. The team collaborates to transform the standard of care, making therapies more patient-friendly and effective, even for the most challenging conditions.